SG/PUT/NOVO-NORDISK B/800/0.1/20.09.24 Stock

Warrant

DE000SU0SM82

Delayed Deutsche Boerse AG 02:47:24 2024-07-17 am EDT
0.11 EUR -8.33% Intraday chart for SG/PUT/NOVO-NORDISK B/800/0.1/20.09.24
Current month-7.69%
1 month-25.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-17 0.11 -8.33%
24-07-16 0.12 0.00%
24-07-15 0.12 +9.09%
24-07-12 0.11 -15.38%
24-07-11 0.13 +8.33%

Delayed Quote Deutsche Boerse AG

Last update July 17, 2024 at 02:47 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SU0SM8
ISINDE000SU0SM82
Date issued 2023-10-16
Strike 800 kr
Maturity 2024-09-20 (66 Days)
Parity 10 : 1
Emission price 1.99
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.33
Lowest since issue 0.092
Delta0x
Omega 0.000000
Premium0x
Gearing108.28x
Moneyness 0.8247
Difference Strike -132.9 kr
Difference Strike %-16.61%
Spread 0.02
Spread %15.38%
Intrinsic value 0.000000

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
970 DKK
Average target price
956.8 DKK
Spread / Average Target
-1.36%
Consensus